The interest of Western medicine in Traditional Chinese Medicine (TCM) as a source of drug leads/new drugs to treat diseases without available efficienttherapieshasbeendramaticallyaugmentedinthelastdecadesbytheextensiveworkandtheoutstandingfindingsachievedwithinthiskind ofmedicine.ThepracticeofTCMoverthousandsofyearshasequippedscientistswithsubstantialexperiencewithhundredsofplantsthatledtothe discovery of artemisinin (qinghaosu), which is extracted from the medicinal plant Artemisia annua L. (qinghao). The unexpected success of artemisinin in combatingmalariahas drawn strongattentionfromthe scientificcommunity towardsTCM. Artemisinin was discovered byYouyou Tu in 1972. Since then, several novel pharmacological activities based on the well-known properties of the sesquiterpene lactone structure with the oxepane ring and an endoperoxide bridge have been unravelled. Beyond malaria, artemisinin and its derivatives (artemisinins) exert profound activities towards other protozoans (Leishmania, Trypanosoma, amoebas,Neospora caninum, andEimeria tenella), trematodes (Schistosoma, liver flukes), and viruses (human cytomegalovirus, hepatitis B and C viruses). Less clear is the effect against bacteria and fungi. Based on the promising results of artemisinin and the first generation derivatives (artesunate, artemether, arteether), novel drug development strategies have been pursued. These included the synthesis of acetal- and non-acetal-type artemisinin dimeric molecules as well as developing nanotechnological approaches, e.g. artemisinin-basedliposomes,niosomes,micelles,solidlipidnanocarriers,nanostructuredlipidcarriers,nanoparticles,fullerenesandnanotubes.The current review presents an overview on different aspects of artemisinins, including sources, chemistry, biological/pharmacological properties, types ofinfectiouspathogensthataresusceptibletoartemisininsinvitroandinvivo,inadditiontotheadvancementintheirdrugdeliverysystemsutilizing pharmaceutical technology. It would be expected that different therapeutic strategies based on the second and third generation artemisinin derivatives and artemisinin-based drug technologies would be available in the near future to treat specific infectious diseases.

Expanding the therapeutic spectrum of artemisinin: Activity against infectious diseases beyond malaria and novel pharmaceutical developments / Thomas Efferth; Marta R. Romero; Anna Rita Bilia; Ahmed Galal Osman; Mahmoud ElSohly; Michael Wink; Rudolf Bauer; Ikhlas Khan; Maria Camilla Bergonzi; Jose J.G. Marin. - In: WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE. - ISSN 2311-8571. - ELETTRONICO. - (2016), pp. 1-23.

Expanding the therapeutic spectrum of artemisinin: Activity against infectious diseases beyond malaria and novel pharmaceutical developments

BILIA, ANNA RITA;BERGONZI, MARIA CAMILLA;
2016

Abstract

The interest of Western medicine in Traditional Chinese Medicine (TCM) as a source of drug leads/new drugs to treat diseases without available efficienttherapieshasbeendramaticallyaugmentedinthelastdecadesbytheextensiveworkandtheoutstandingfindingsachievedwithinthiskind ofmedicine.ThepracticeofTCMoverthousandsofyearshasequippedscientistswithsubstantialexperiencewithhundredsofplantsthatledtothe discovery of artemisinin (qinghaosu), which is extracted from the medicinal plant Artemisia annua L. (qinghao). The unexpected success of artemisinin in combatingmalariahas drawn strongattentionfromthe scientificcommunity towardsTCM. Artemisinin was discovered byYouyou Tu in 1972. Since then, several novel pharmacological activities based on the well-known properties of the sesquiterpene lactone structure with the oxepane ring and an endoperoxide bridge have been unravelled. Beyond malaria, artemisinin and its derivatives (artemisinins) exert profound activities towards other protozoans (Leishmania, Trypanosoma, amoebas,Neospora caninum, andEimeria tenella), trematodes (Schistosoma, liver flukes), and viruses (human cytomegalovirus, hepatitis B and C viruses). Less clear is the effect against bacteria and fungi. Based on the promising results of artemisinin and the first generation derivatives (artesunate, artemether, arteether), novel drug development strategies have been pursued. These included the synthesis of acetal- and non-acetal-type artemisinin dimeric molecules as well as developing nanotechnological approaches, e.g. artemisinin-basedliposomes,niosomes,micelles,solidlipidnanocarriers,nanostructuredlipidcarriers,nanoparticles,fullerenesandnanotubes.The current review presents an overview on different aspects of artemisinins, including sources, chemistry, biological/pharmacological properties, types ofinfectiouspathogensthataresusceptibletoartemisininsinvitroandinvivo,inadditiontotheadvancementintheirdrugdeliverysystemsutilizing pharmaceutical technology. It would be expected that different therapeutic strategies based on the second and third generation artemisinin derivatives and artemisinin-based drug technologies would be available in the near future to treat specific infectious diseases.
2016
1
23
Thomas Efferth; Marta R. Romero; Anna Rita Bilia; Ahmed Galal Osman; Mahmoud ElSohly; Michael Wink; Rudolf Bauer; Ikhlas Khan; Maria Camilla Bergonzi;...espandi
File in questo prodotto:
File Dimensione Formato  
WJTCM artemisinina 2016.pdf

Accesso chiuso

Descrizione: Articolo principale
Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1079796
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? ND
social impact